Best for
All-rounder

Agilent Technologies, Inc (A) is a leading diagnostics & research business based in the US. It opened the day at $118.67 after a previous close of $118.81. During the day the price has varied from a low of $117.29 to a high of $119.06. The latest price was $118.48 (25 minute delay). Agilent Technologies is listed on the NYSE and employs 16,400 staff. All prices are listed in US Dollars.
Best for
All-rounder
Best for
Low-cost trading
Best for
US shares
Best for
Beginners
Since the stock market crash in March caused by coronavirus, Agilent Technologies's share price has had significant positive movement.
Its last market close was $105.49, which is 19.36% up on its pre-crash value of $85.07 and 72.57% up on the lowest point reached during the March crash when the shares fell as low as $61.13.
If you had bought $1,000 worth of Agilent Technologies shares at the start of February 2020, those shares would have been worth $771.21 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,283.81.
Open | $118.67 |
---|---|
High | $119.06 |
Low | $117.29 |
Close | $118.48 |
Previous close | $118.81 |
Change | $-0.33 |
Change % | -0.278% |
Volume | 1,400,768 |
52-week range | $60.7376 - $120.24 |
---|---|
50-day moving average | $114.2735 |
200-day moving average | $101.4079 |
Wall St. target price | $121.94 |
PE ratio | 51.0044 |
Dividend yield | $0.78 (0.66%) |
Earnings per share (TTM) | $2.3 |
Other fees may apply. Your capital is at risk.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of $118.48
1 week (2021-01-08) | -6.75% |
---|---|
1 month (2020-12-18) | -0.69% |
3 months (2020-10-16) | 11.04% |
6 months (2020-07-17) | 25.55% |
1 year (2020-01-17) | 31.47% |
---|---|
2 years (2019-01-17) | 67.30% |
3 years (2018-01-17) | 64.42% |
5 years (2016-01-15) | 219.27% |
Valuing Agilent Technologies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Agilent Technologies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Agilent Technologies's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 51x. In other words, Agilent Technologies shares trade at around 51x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
However, Agilent Technologies's P/E ratio is best considered in relation to those of others within the diagnostics & research industry or those of similar companies.
Agilent Technologies's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.0037. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Agilent Technologies's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
However, it's sensible to consider Agilent Technologies's PEG ratio in relation to those of similar companies.
Agilent Technologies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $1.4 billion (£0.0 million).
The EBITDA is a measure of a Agilent Technologies's overall financial performance and is widely used to measure a its profitability.
To put Agilent Technologies's EBITDA into context you can compare it against that of similar companies.
Revenue TTM | $5.3 billion |
---|---|
Operating margin TTM | 19.55% |
Gross profit TTM | $2.8 billion |
Return on assets TTM | 6.84% |
Return on equity TTM | 14.95% |
Profit margin | 13.47% |
Book value | $15.915 |
Market capitalisation | $36 billion |
TTM: trailing 12 months
There are currently 3.2 million Agilent Technologies shares held short by investors – that's known as Agilent Technologies's "short interest". This figure is 3.9% up from 3.1 million last month.
There are a few different ways that this level of interest in shorting Agilent Technologies shares can be evaluated.
Agilent Technologies's "short interest ratio" (SIR) is the quantity of Agilent Technologies shares currently shorted divided by the average quantity of Agilent Technologies shares traded daily (recently around 2.1 million). Agilent Technologies's SIR currently stands at 1.53. In other words for every 100,000 Agilent Technologies shares traded daily on the market, roughly 1530 shares are currently held short.
To gain some more context, you can compare Agilent Technologies's short interest ratio against those of similar companies.
However Agilent Technologies's short interest can also be evaluated against the total number of Agilent Technologies shares, or, against the total number of tradable Agilent Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Agilent Technologies's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Agilent Technologies shares in existence, roughly 10 shares are currently held short) or 0.0105% of the tradable shares (for every 100,000 tradable Agilent Technologies shares, roughly 11 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Agilent Technologies.
Find out more about how you can short Agilent Technologies stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Agilent Technologies.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 17.72
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Agilent Technologies's overall score of 17.72 (as at 01/01/2019) is excellent – landing it in it in the 12nd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Agilent Technologies is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
To gain some more context, you can compare Agilent Technologies's total ESG risk score against those of similar companies.
Environmental score: 0.63/100
Agilent Technologies's environmental score of 0.63 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Agilent Technologies is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 9.4/100
Agilent Technologies's social score of 9.4 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Agilent Technologies is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 5.95/100
Agilent Technologies's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that Agilent Technologies is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Agilent Technologies scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Agilent Technologies has, for the most part, managed to keep its nose clean.
Wondering how that compares? Below are the controversy scores of similar companies.
Agilent Technologies, Inc was last rated for ESG on: 2019-01-01.
Total ESG score | 17.72 |
---|---|
Total ESG percentile | 11.7 |
Environmental score | 0.63 |
Environmental score percentile | 2 |
Social score | 9.4 |
Social score percentile | 2 |
Governance score | 5.95 |
Governance score percentile | 2 |
Level of controversy | 2 |
Dividend payout ratio: 22.38% of net profits
Recently Agilent Technologies has paid out, on average, around 22.38% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.66% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Agilent Technologies shareholders could enjoy a 0.66% return on their shares, in the form of dividend payments. In Agilent Technologies's case, that would currently equate to about $0.78 per share.
While Agilent Technologies's payout ratio might seem low, this can signify that Agilent Technologies is investing more in its future growth.
Agilent Technologies's most recent dividend payout was on 27 January 2021. The latest dividend was paid out to all shareholders who bought their shares by 4 January 2021 (the "ex-dividend date").
Agilent Technologies's dividend payout ratio is perhaps best considered in relation to those of similar companies.
Agilent Technologies's shares were split on a 1398:1000 basis on 3 November 2014. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1398 shares. This wouldn't directly have changed the overall worth of your Agilent Technologies shares – just the quantity. However, indirectly, the new 28.5% lower share price could have impacted the market appetite for Agilent Technologies shares which in turn could have impacted Agilent Technologies's share price.
Over the last 12 months, Agilent Technologies's shares have ranged in value from as little as $60.7376 up to $120.24. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Agilent Technologies's is 1.0546. This would suggest that Agilent Technologies's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
To put Agilent Technologies's beta into context you can compare it against those of similar companies.
Subscribe to trending stock alerts for a chance to win
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass and optical emission spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software, information management, and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment to produce synthesized oligonucleotide. It also offers immunohistochemistry, in situ hybridization, and hematoxylin and eosin staining and special staining; instruments, consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. It has collaboration agreement with SGS AXYS. The company was incorporated in 1999 and is headquartered in Santa Clara, California.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.